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Background: Adiponectin and leptin are implicated in the initiation and
pathomechanism of Alzheimer’s disease (AD). The serum concentrations of these
adipokines has been extensively studied in AD, however little is known about their
receptors in this disease.
Objective: We developed a novel approach to examine whether the receptors
of adiponectin (AdipoR1 and -R2) and/or leptin (LepR) can contribute to AD
pathomechanism. To achieve this, we investigated the effect of both genetic and
environmental factors associated with AD on the expression of these receptors.
Method: We used C57BL/6J (WT) and APP(swe)/Presen(e9d)1 (AD) mice. Both strains
were exposed to restraint stress (RS) daily for 6h over different time periods. Then,
we measured the mRNA expression of AdipoR1, AdipoR2 and LepR and the level of
AdipoR1 and AdipoR2 proteins in the hippocampal and prefrontal cortical areas of each
mouse.
Results: We detected brain region specific transcriptomic changes of adiponectin
receptors induced by APP and PS1 transgenes. Both acute and chronic RS caused
significant elevations in AdipoR1 mRNA expression in the hippocampus of WT mice. In
the prefrontal cortex, the mRNA expression of AdipoR1 followed a biphasic course. In
AD mice, RS did not promote any changes in the expression of AdipoR1 mRNA and
AdipoR1 protein levels. AdipoR2 mRNA in AD animals, however, showed a significant
increase in the prefrontal cortex during RS. Regarding AdipoR1 and AdipoR2 mRNA
and protein expression, relevant changes could be measured during stress exposure in
both brain areas. Furthermore, stress exposed groups exhibited little change in LepR
mRNA expression.
Conclusion: Our findings indicate that carrying the transgenes associated with AD
induces modification in the expression of both adiponectin receptors. In the case of a
normal genetic background, these receptors also appear to be sensitive to environmental
factors, while in a genetically determined AD model less response to stress stimuli could
be observed. The results suggest that modification of adipokine receptors could also be
considered in the therapeutic approach to AD.
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INTRODUCTION
Alzheimer’s disease (AD) is one of the most common forms
of neurodegenerative dementia, being responsible for 60–80%
of all recorded dementia cases (Alzheimer’s Association, 2015).
The pathogenesis of AD appears to be multifactorial in nature,
with both genetic and environmental factors contributing to
the development and progression of the disease. For example,
obesity and one of its comorbidities, metabolic syndrome, are
also associated with AD pathogenesis. Studies hint at the fact that
members of the adipokine molecular group may be involved in
the link between obesity and AD. Adiponectin and leptin are
the most well characterized adipokines regarding their role in
AD. These small peptides have two common traits: (1) They
can be synthesized by the adipose tissue; (2) they have a specific
cytokine and/or hormone function (Alzheimer’s Association,
2015). Recently a model was proposed suggesting that decreased
plasma adiponectin and increased plasma leptin concentrations,
due to obesity in mid-life, can make the brain more susceptible
to dementia, whereas weight loss in late-life and during the early
periods of dementia leads to lower leptin and higher adiponectin
levels and may have the same results, also contributing to the
progression of neurodegeneration (Ishii and Iadecola, 2016).
The level of the 30 kDa adipocyte-derived polypeptide,
adiponectin, is inversely associated with metabolic syndrome.
Not only individual investigations (Une et al., 2011; Khemka
et al., 2014), but also a meta-analysis, demonstrated the higher
serum levels of adiponectin in AD patients (Ma et al., 2016). It
has been found that an upregulation in adiponectin expression
may be associated with mild cognitive impairment (MCI)
and AD (Une et al., 2011). In addition, higher adiponectin
levels were associated with smaller hippocampal volume, poorer
performance in language, memory and global cognitive domains,
and higher odds of MCI among women (Wennberg et al.,
2016). Adiponectin has been proposed as a therapeutic target
in certain cognitive deficiencies (Chan et al., 2012; Diniz et al.,
2012). Adiponectin exerts its effects by binding to its two
transmembrane receptors, adiponectin receptor 1 (AdipoR1) and
adiponectin receptor 2 (AdipoR2), which are widely expressed
in various areas of the brain, including the hippocampus (Qiu
et al., 2011). Adiponectin enhances AMP-activated protein kinase
(AMPK) activity via AdipoR1 to stimulate food intake and
decrease energy consumption (Kadowaki et al., 2008). Also,
AMPK activation represses amyloidogenesis, decreases mTOR
signaling and enhances autophagy and lysosomal degradation of
Aβ (Godoy et al., 2014). Adiponectin secretion is also upregulated
by PPAR-γ induced activation of AdipoR2 (Kadowaki et al.,
2008). The mechanistic link between PPAR-γ and amyloid
clearance has been demonstrated to ameliorate the pathological
and behavioral deficits in an AD mouse model (Mandrekar-
Colucci et al., 2012). This is in contrast with the fact that both
adiponectin receptors are involved in the regulation processes of
amyloidogenesis. However, these receptors have not been studied
in AD patients or in any animal models of the disease.
Leptin is a small, 16 kDa adipose-derived hormone which
was found to be in lower concentrations in the blood of AD
patients (Power et al., 2001). At the same time, the level of leptin
in the cerebrospinal fluid (CSF) in a small cohort of patients
with AD was significantly elevated (Bonda et al., 2014). Recently,
another research group observed no difference in the CSF leptin
levels of patients with AD or MCI (Maioli et al., 2015). One
possible explanation for the paradoxical findings may lie in the
signaling pathway of leptin in the central nervous system. Leptin
receptor (LepR) activation in hippocampal neurons may play an
important role in the memory of mice in relation to food intake
and learning (Kanoski et al., 2011). By binding to LepR, leptin
activates several intracellular signaling pathways, including signal
transducer and activator of transcription 3 (STAT3), mitogen-
activated protein kinase (MAPK) and phosphatidylinositol 3-
kinase (PI3K) pathways to reduce the risk of AD (Li et al.,
2016).
In addition to obesity, another possible environmental
component in AD induction is psychological stress.
Epidemiological studies indicate that stress is associated
with increased risk of dementia and AD (Wilson et al., 2006).
Repeated exposure of rats to mild stressors resulted in enhanced
expression of adiponectin mRNA, suggesting that adipose tissue
is sensitive to environmental stress (Sato et al., 2011). However,
the effect of stress on the expression of adiponectin receptors
has not yet been published in a scientific paper. Different types
of acute stress, such as immobilization, forced swimming or
noise increased the circulating levels of leptin (Haleem, 2014).
Unlike acute stress, chronic unpredictable mild stress induced
a decrease in serum leptin levels and in hypothalamic leptin
receptor mRNA expression (Ge et al., 2013).
The primary aim of this study was to investigate the mRNA
and protein expression of AdipoR1, AdipoR2 and leptin receptor
(LepR) in an amyloid precursor protein (APP)/presenilin-1 (PS1)
transgenic mouse model. Since obesity and stressful life events
frequently co-occur, we also wanted to examine the effect of
restraint stress (RS) on these adipokine receptors’ expression in a
quantifiablemanner to find out whether stress, as a possible factor
in the development of AD,may be able to influence AD pathology
through these receptors. As AD affects the hippocampus and the
prefrontal cortex most prominently, we selected these brain areas
as the focal points of our experiment.
MATERIALS AND METHODS
Animals
Two separate mouse strains were used: a wild type C57BL/6J
mouse strain (WT mice, n = 30) and an APP(swe)/PS1(e9d)1
transgenic mouse strain (AD mice, n = 30). Transgenic mice
were purchased from the Jackson Laboratory (Bar Harbor,
ME, USA). The double transgenic mice express a chimeric
mouse/human amyloid precursor protein (Mo/HuAPP695swe)
and a DeltaE9 mutant human presenilin 1 (PS1-dE9), both
directed to CNS neurons. Both mutations are associated with
the early onset of AD. The two transgenes were inserted at a
single locus in Chromosome 9 between Arpp21 and Pdcd6ip. The
“humanized” Mo/HuAPP695swe transgene allows the mice to
secrete a human A-beta peptide. The included Swedishmutations
(K595N/M596L) also elevate the amount of A-beta produced
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from the transgene by favoring processing through the beta-
secretase pathway. Mice carrying this double transgene develop
beta-amyloid deposits in the brain by 6–7 months of age.
Hemizygous mice on the C57BL/6 background (N9B6) exhibit
a high incidence of seizures (by 4.5 months of age, seizure
incidence increases to 55%). Furthermore, these animals may
display a slight alteration in their tail phenotype (e.g., kinked tail)
that is believed to be due to the mixed genetic background of the
strain and is not related to transgene expression. Mouse Strain
Datasheet (2016)1.
Mice were 23–33 weeks old at the start of the experiment. Only
male animals were used. All mice were maintained under a 12-
h light/dark cycle (from 08:30 to 20:30) at constant temperature
(22 ± 1◦C) and humidity (55 ± 5%) with free access to food (rat
chow pellets) and tap water. All experiments using live animals
were performed in accordance with the protocols approved
by the regional Hungarian Animal Health and Food Control
Station and the University of Szeged (I-74-4/2011.MÁB.SZ). This
study was carried out in strict accordance with EU Directive
2010/63/EU. Euthanasia of animals were performed under deep
sodium pentobarbital (Nembutal) anesthesia, and all efforts were
made to minimize suffering.
Stress Exposure
RS was applied based on our previous results (Santha et al., 2012,
2015). The animals were placed in well-ventilated, darkened, 50-
ml centrifuge tubes for 6 h every morning (Freeman et al., 2007).
Five groups were created from both mouse strains, every group
consisted of 6 animals. The groups were the following: group
1/wt and 1/AD (n = 6) were controls; group 2/wt and 2/AD (n
= 6) underwent 3 days of RS; group 3/wt and 3/AD underwent
7 days of RS; group 4/wt and 4/AD (n = 6) underwent 14 days
of RS; group 5/wt and 5/AD (n = 6) underwent 21 days of RS.
Control animals remained in their original boxes and were left
undisturbed. The body weight of the animals was measured at the
beginning of the experiment and after every RS treatment period
(at 3, 7, 14, and 21 days).
Tissue Collection
RS exposed animals were anesthetized within 24 h from the last
day of RS with a 50 mg/ml solution of sodium pentobarbital in
sterile saline, administered IP at a dose of 70 mg/kg. Control
animals (group 1) were euthanized with the 21-day RS animals
(group 5). The animals under deep anesthesia were perfused
transcardially with a 4◦C, 0.9% normal saline solution, then
the brain was removed, the hippocampus and prefrontal cortex
were isolated from both the left and right hemispheres and the
resulting samples were stored at−80◦C until further use.
Total DNA, RNA and Protein Isolation
Total cellular DNA, RNA and protein species were purified from
the hippocampus and prefrontal cortex using the NucleoSpin R©
Triprep isolation kit (Macherey-Nagel GmbH & Co. KG, Düren,
Germany), based on the manufacturer’s instructions. 0.5 µl of
RNase inhibitor 40 U/µl (Fermentas, Glen Burnie, ML, USA)
1B6C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax Mouse Strain Datasheet
(2016).2017.
was added to the eluted RNA. The resulting 40 µl eluted
RNA,100 µl eluted genomic DNA (gDNA) and the 500 µl eluted
protein samples’ concentrations were measured with the Qubit
2.0 Fluorometer R© (Life Technologies, Thermo Fisher Scientific
Inc., Waltham, MA, USA) using the Qubit R© High Sensitivity
mRNA Assay Kit, High Sensitivity DNA Assay Kit and Protein
Assay Kit, respectively. The samples were stored at −80◦C until
further use.
RT-qPCR Analysis of AdipoR1, AdipoR2
and LepR mRNA Expression
The mRNA expression of AdipoR1, AdipoR2, and LepR
were measured by a two-step real-time reverse transcription
polymerase chain reaction (RT-qPCR) with the CFX96 TouchTM
Real-Time PCR Detection System (Bio-Rad Laboratories Inc.,
Hercules, CA, USA).
The High Capacity cDNA Reverse Transcription kit (Life
Technologies, Thermo Fisher Scientific Inc., Waltham, MA,
USA) was used for reverse transcription, based on the
manufacturer’s instructions. From each sample 2 µg RNA was
transcribed to cDNA. The total volume of each reaction was 30
µL. The three thermal cycle steps were the following: 25◦C for
10min, 37◦C for 120 min, and 85◦C for 5 s after which each
sample was cooled down to 4◦C. The transcribed cDNA samples
were then diluted in 510 µL nuclease-free water and were stored
at−20◦C until further use.
At the qPCR step, SybrGreen-based detection was used for the
measurement of AdipoR1 and R2, while TaqMan-based detection
was applied for determining LepR. This was to prevent false
results in the detection of LepR caused by transcript variants
of highly similar sequence transcribed from the LEPR gene. For
SybrGreen-based detection, qPCR was performed with a final
volume of 20 µl, containing 9 µl of diluted cDNA, 0.5 µl of
reverse primer, 0.5 µl of forward primer, and 10 µl of SYBR R©
Select Master Mix for CFX (Life Technologies, Thermo Fisher
Scientific Inc., Waltham, MA, USA). The cDNA specific primers
for AdipoR1, AdipoR2 and GAPDH mRNA were designed with
the help of the NCBI Gene database and the NCBI Primer-
BLAST tool. The cycle protocol provided by the manufacturer,
repeated 40 times per run, was used for detection. At the end
of each run, melt curve analysis was performed to ensure the
quality of the acquired data. The analysis was carried out between
55◦C and 93◦C with a 0.2◦C temperature increment per 10 s per
step. The relative gene expression was normalized to GAPDH
expression and the results were first analyzed with the 11Cq
method (Livak and Schmittgen, 2001) and later with a gDNA-
based quantification, detailed below. The sequence of primers are
shown in Table 1.
For TaqMan-based detection, qPCR was performed with a
final volume of 20 µl. The cycle protocol provided by the
manufacturer was used for detection, which was repeated 40
times per run. The relative gene expression was normalized
to GAPDH expression and the results were analyzed with the
11Cq method (Livak and Schmittgen, 2001).
Quantification of RT-qPCR Data
The RT-qPCR data for the AdipoR1 and R2 mRNA was
quantified from a mouse gDNA standard curve according to Yun
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TABLE 1 | List of primers used.
Gene Forward 5′–3′ Reverse 5′–3′ Length of amplicons
AdipoR1 CCTGTCCACCATCACAGGAA GTGGGAAGACATCTGGCTGG 108
AdipoR2 AACTCTGACAGGATTTGGGGTC CAATCGGTGTTTGGCTGGCT 133
GAPDH TGTGTCCGTCGTGGATCTGA TTGCTGTTGAAGTCGCAGGAG 150
et al. (2006). From the previously isolated and measured mouse
gDNA samples, five were randomly selected that were sheared by
needle point shearing. After shearing, 5 quantities were produced
from the cDNA samples with a threefold dilution ranging from 9
to 0.111 ng, respectively. The approximate AdipoR1 and R2 gene
copy numbers of each quantity were calculated using the mass of
the average haploid mouse genome and the adiponectin receptor
genes’ genomic copy number in mouse. All the gDNA dilutes of
the different samples were amplified with the same protocol and
primers used for the qPCR analysis described previously. From
the resulting data a standard curve of Ct vs. copy number was
generated.
Elisa of AdipoR1 and AdipoR2
Mouse AdipoR1 specific antibody-coated, 96-well enzyme-
linked immunosorbent assay (ELISA) plates and AdipoR2
specific antibody-coated, 96-well ELISA plates (Sanghai Sunred
Biological Technology Co., Ltd., Shanghai, PRC) were used
following the manufacturer’s instructions. For the control and
four stress-exposed groups of both mouse strains in our
experiment, three protein samples were randomly selected from
the six available samples. The total protein concentration loaded
into each well was 20 µg/ml in a 40 µl volume. The final OD
values were measured with the SpectraMax R© Plus384 (Molecular
Devices, LLC., Sunnyvale, CA, USA) absorbance microplate
reader and sample protein concentration was calculated with
the SoftMax R© Pro Data Acquisition and Analysis Software
(Molecular Devices, LLC., Sunnyvale, CA, USA).
Statistical Analysis
The stress-exposed groups were compared to their respective
controls (per gene, per brain area and per mouse strain) by one-
way analysis of variance (ANOVA) followed by Bonferroni and
Tukey post hoc tests. The comparison between the same stress-
treated, but different mouse strain, samples in every brain area
for the studied genes was performed using Welch’s two sample
t-test. Results were considered to be significantly different at a
probability level of p < 0.05 and lower (p < 0.01; p < 0.001).
Data are presented as means plus standard error of means (SEM).
For every statistical calculation we used the “R: A language and
environment for statistical computing” (Version: 3.1.2; The R
Foundation for Statistical Computing, Vienna, Austria) and the
“R Studio: Integrated development environment for R” (Version:
0.98.1091, R Studio Co., Boston, MA, USA) statistical software.
Plot.ly Software (Plotly Technologies Inc. Collaborative data
science. Montréal, QC, 2016. https://plot.ly.) and its built-in
algorithms were used to create the boxplot data presented in this
article.
RESULTS
AdipoR1 and AdipoR2 mRNA Expression in
the WT and APP/PS1 Mice
Earlier studies focus mostly on the higher systemic concentration
of adiponectin related to AD (Ishii and Iadecola, 2016), however
the background of the adiponectin-AD connection remains
unclear.
For this reason, first we intended to compare the expression
of AdipoR1 and AdipoR2 mRNA between WT and AD mice.
Regarding the two examined brain regions, significantly higher
AdipoR1 mRNA levels have been found in the prefrontal cortex
compared to the hippocampus in both WT and APP/PS1
transgenic mice (Figure 1A). Additionally, AdipoR1 mRNA
expression is significantly higher in the hippocampus of AD
mice than in WT, while in the prefrontal cortex AdipoR1 mRNA
did not differ between the two strains (Figure 1A). AdipoR2
hippocampal mRNA levels were equal in the WT and AD
models, but in WT mice its expression (similarly to AdipoR1)
was lower in the hippocampus compared to the prefrontal
cortex (Figure 1B). Furthermore, AdipoR2 mRNA expression
wasmuch lower in the prefrontal cortex of AD animals compared
to their WT counterparts (Figure 1B). Interestingly, mRNA
expression of AdipoR1 was 8.3 and10 times higher compared
to the expression of AdipoR2 in both the hippocampus and in
the prefrontal cortex, respectively (Figure 1). In APP/PS1 mice,
since only the AdipoR1 mRNA levels elevated and AdipoR2
mRNA levels did not, the difference in the expression between
the two receptors further increased up to 15.5 and 23 times
in the hippocampus and prefrontal cortex, respectively. Taken
together, these data show that there are indeed differences in
adiponectin receptor mRNA expression between the WT and
APP/PS1 transgenic mice and even between the two examined
brain areas in each strain.
AdipoR1 and AdipoR2 Proteins in the WT
and the APP/PS1 Mice
Our next goal was to investigate whether there are similar
differences in adiponectin receptor protein concentrations to
what was observed in the mRNA levels. We used ELISA
kits to measure the exact protein concentration of AdipoR1
and AdipoR2 in both strains and both brain areas. Lower
hippocampal AdipoR1 protein expression was detected in the
APP/PS1 transgenic mice compared to the WT ones (Figure 2A,
Supplementary Table 2). Furthermore, in the WT strain there
were no differences in protein level of either receptor between
the two regions. However, in AD mice, AdipoR1 receptor
levels were lower in the hippocampus than in the prefrontal
Frontiers in Neuroscience | www.frontiersin.org 4 April 2017 | Volume 11 | Article 199
Várhelyi et al. Adiponectin Receptors in Alzheimer’s Disease
FIGURE 1 | AdipoR1 (A) and AdipoR2 (B) mRNA expression in WT and AD mouse hippocampus and prefrontal cortex. The mouse strains were compared by
Welch’s two sample t-tests (per gene, per brain area), data are expressed as means + SEM. (n = 6), ***p < 0.001; **p < 0.01.
cortex (Figure 2A). We found no significant differences in
AdipoR2 hippocampal and prefrontal cortical protein expression
between WT and AD animals (Figure 2B). In summary, these
data demonstrate that protein levels differ greatly from mRNA
expression for the two adiponectin receptors. The 8.3–10 fold
difference between AdipoR1 and AdipoR2 which we observed at
the mRNA level was almost completely abolished at the protein
level. These results may suggest strong, genetically determined
pre- and/or post-translational regulation of these receptors.
The Effect of Restraint Stress on AdipoR1
and AdipoR2 mRNA Expression
Long-term mild common stressors may influence the risk of AD
development during an individual’s lifetime. It has been shown,
that adiponectin expression is sensitive to environmental stress.
To gain further information related to stress-induced changes,
we wanted to investigate whether acute or chronic stresses can
influence the expression of AdipoR1 and AdipoR2 mRNA levels.
As shown in Figure 3, both acute (day 3) and chronic (day 7,
14, and 21) RS caused significant, almost twofold, elevations in
AdipoR1 mRNA expression in the hippocampus of WT mice,
while in APP/PS1 mice only a smaller decrease could be observed
after 7 days of stress treatment (Figure 3A). In the prefrontal
cortex, the mRNA expression of AdipoR1 followed a biphasic
course, it increased in the cases of the shorter RS (3 day and day
7), while a sharp drop could be observed after a longer period
of RS (day 14 and day 21) (Figure 3B). These data demonstrate
that even really short term (3 day) stress can induce an elevation
in AdipoR1 mRNA production in both examined brain areas of
WT mice. This is consistent with a previous report, stating that
repeated exposure to stresses causes enhanced gene expression
of adiponectin in gonadal white adipose tissue. In AD mice, RS
did not induce any change in the expression of AdipoR1 mRNA
either in the hippocampus (Figure 3A) or the prefrontal cortex
(Figure 3B), except a transient decrease in hippocampal AdipoR1
mRNA in the 7th day (Figure 3A).
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FIGURE 2 | AdipoR1 (A) and AdipoR2 (B) protein expression in WT and AD mouse hippocampus and prefrontal cortex. The mouse strains were compared by
Welch’s two sample t-tests (per gene, per brain area), data are expressed as means + SEM. (n = 3), **p < 0.01.
AdipoR2 mRNA reacted to stress in the hippocampus largely
in a similar manner to what was observed for AdipoR1 in WT
mice: The expression of AdipoR2 mRNA increased significantly
only on days 3 and 7 (Figure 4A). In AD mice, hippocampal
AdipoR2 mRNA levels remained unchanged at every time point
during RS. In the prefrontal cortex of WT mice, the AdipoR2
mRNA expression showed a steady decrease during RS, which
reached its lowest levels by day 7 and 14 (Figure 4B). In
contrast, AdipoR2 mRNA localized in the prefrontal cortex
of AD animals was found to be strongly elevated by days 3,
7, and 14 and moderately by day 21 (Figure 4B). Thus, our
results showed a completely different pattern for AdipoR2’s
prefrontal cortical expression in our two strains with the
receptor’s expression decreasing in the WT and increasing in
the transgenic animals. Exact points of adiponectin receptor
mRNA expression data are summarized in the Supplementary
Table 1.
The Effect of Restraint Stress on AdipoR1
and AdipoR2 Protein Expression
Next, we measured AdipoR1 and AdipoR2 protein
concentrations using ELISA kits on three randomly selected
samples in both strains at each time point of RS. The protein
expression of AdipoR1 showed quite the opposite to what we
saw at the mRNA level. Despite the fast and constant elevation in
AdipoR1 mRNA in the hippocampus of WT mice, a significant
decrease in AdipoR1 protein levels was induced by chronic,
21-day stress (Figure 5A). Hippocampal AdipoR1 expression in
AD mice showed an elevation on day 7 (Figure 5A), in contrast
to mRNA expression, which was lower in the 7-day group
compared to the control. In the prefrontal cortex, RS did not
cause any significant changes in AdipoR1 protein levels in either
WT or AD mice (Figure 5B), meaning that the biphasic change
we observed in the WT AdipoR1 mRNA concentration did not
translate to the protein level.
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FIGURE 3 | Effects of restraint stress on the expression of AdipoR1 mRNA in the hippocampus (A) and prefrontal cortex (B) of the wild type and APP/PS1
transgenic mice. Stress-exposed groups were compared to their respective controls (per gene, per brain area, and per mouse strain) by one-way analysis of variance
(ANOVA) followed by Bonferroni and Tukey post hoc tests. Data are expressed as means + SEM (n = 6), *p < 0.05; **p < 0.01. The gray lines represent linearized
(A,B, APP/PS1 strain) and polynomial (B, WT strain) trends of change in the two strains.
As in AdipoR1, AdipoR2’s protein levels were decreased
in the hippocampus of WT mice in every stress-exposed
group (day 3, 7, 14, or 21) (Figure 6A), despite the increased
production of its mRNA caused by short term (3 and 7
day) stress. As for the AD animals, only the longer, chronic
(day 21) RS induced a mild, but significant, decrease in
AdipoR2 protein levels in the hippocampus compared to the
control group. In the prefrontal cortex of WT mice, AdipoR2
levels showed the same tendency as in the hippocampus, the
reduction was significant on the 7th, 14th, and 21st days
(Figure 6B). This AdipoR2 protein expression pattern was the
only dataset where the protein levels matched the mRNA
levels. Furthermore, in stress-exposed AD animals, the prefrontal
cortical levels of AdipoR2 did not differ from those of the
control group (Figure 6B). Exact points of protein adiponectin
receptor expression data are summarized in the Supplementary
Table 2.
The Effect of Restraint Stress on LepR
mRNA Expression in WT and APP/PS1
Animals
It can be suggested, that the decreased level of LepR may be a
possible cause of leptin insensitivity, which has been described
in AD. Therefore, we used TaqMan based PCR chemistry to
precisely measure the LEPR long isoform mRNA in our samples,
which is solely responsible for coding LepR.
The resulting data indicated that RS did not induce any
consistent changes in the hippocampal LepR mRNA expression
in WT mice (Figure 7A). However, in the prefrontal cortical
area, chronic RS resulted in a significant decrease in LepR
mRNA expression by day 7. Then LepR mRNA returned to
the control group’s level again by day 14, and finally elevated
significantly by day 21 (Figure 7B). In APP/PS1 transgenic mice,
only the longer, 21-day RS caused significant LepR mRNA
reduction in the hippocampus (Figure 7A). In conclusion, for
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FIGURE 4 | Effects of restraint stress on the expression of AdipoR2 mRNA in the hippocampus (A) and prefrontal cortex (B) of the wild type and APP/PS1
transgenic mice. Stress-exposed groups were compared to their respective controls (per gene, per brain area and per mouse strain) by one-way analysis of variance
(ANOVA) followed by Bonferroni and Tukey post hoc tests. Data are expressed as means + SEM (n = 6), *p < 0.05; **p < 0.01, and ***p < 0.001. The gray lines
represent linearized trends of change in the two strains.
LepR we only identified a few significant differences in our
stress-treated groups, implying that LepR’s expression is not
affected prominently by the APP/PS1 transgenes or by stress.
Furthermore, these data are consistent with the results of Balland
and colleagues, who found that LepR regulation and availability
is not an element in the leptin resistance mechanisms. Exact
points of LepR mRNA expression data are summarized in
Supplementary Table 1.
DISCUSSION
The significant contribution of adiponectin and leptin in the
pathomechanism of AD has been highly researched in the past
few years (Tezapsidis et al., 2009; van Himbergen et al., 2012;
Pedros et al., 2015). However, the exact role of these molecules
in the disease is still very elusive, thanks to their complex
interactions with the CNS. Adiponectin and leptin may not only
be associated with AD via their changed serum concentrations,
but also through other means. The possible target points
regarding the CNSmay be the signaling pathways, more precisely
the receptors of these adipokines (Waragai et al., 2016). Taking
this into consideration, the current study shows that bearing
the APP/PS1 transgenes associated with AD induces altered
expression of AdipoR1 and AdipoR2 in the hippocampus and
the prefrontal cortex. The present paper also demonstrates that
chronic stress, a potential AD inducer, may influence the levels of
both adiponectin receptors in the aforementioned brain areas of
wild type mice. Furthermore, the same receptors responded less
or not at all to identical chronic RS in the APP(swe)/PS1(e9d)1
transgenemurinemodel of AD. The differences in stress response
were stronger at the protein level. Considering LepR mRNA
in the same strains and brain areas, we only detected slight
modifications compared to the adiponectin receptors.
The presence of AdipoR1 and AdipoR2 in several brain areas,
including the frontal cortex and the hippocampus, has been
shown previously (Qiu et al., 2011). However, information on
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FIGURE 5 | Effects of restraint stress on the expression of AdipoR1 protein in the hippocampus (A) and prefrontal cortex (B) of the wild type and APP/PS1
transgenic mice. Stress-exposed groups were compared to their respective controls (per protein, per brain area, and per mouse strain) by one-way analysis of
variance (ANOVA) followed by Bonferroni and Tukey post hoc tests. Data are expressed as means + SEM (n = 3), *p < 0.05.
the AD-related changes of AdipoR1 and AdipoR2 is still very
limited. Therefore, in this study, the expression of adiponectin
receptors mRNA and proteins were quantified for the first time in
WT and APP/PS1 transgenic mice. In contrast with the increased
transcription of the hippocampal AdipoR1, the presence of
the two AD-related transgenes decreased the AdipoR1 protein
levels. These results assume a downregulated signalization of
adiponectin in AD and support earlier findings (Waragai et al.,
2016). In this cross-sectional study, pathologically changed
adiponectin-adiponectin receptor signaling was suggested based
on the higher serum and lower CSF adiponectin levels in AD
patients.
Based on the fact that chronic stress has considerable
effects on cognitive decline and memory loss, a possible link
between psychological stress and AD development has been
suggested (Khalsa, 2015). Our results show that stress stimuli
can downregulate AdipoR1 and AdipoR2 transcription and
translation in the hippocampal and prefrontal cortical areas
of wild type mice. The question arises as to what this stress-
induced modification of adipokine receptors really means for
the pathomechanism of AD. Adiponectin has been reported
to have anti-inflammatory, anti-atherogenic, anti-diabetogenic
and neuroprotective effects (Berg et al., 2002; Qiu et al., 2011;
Ohashi et al., 2012). According to our observations, because
of the decreased availability of AdipoR1 and AdipoR2, the
beneficial properties of adiponectin may diminish during stress;
thus adiponectin may fail to exert its protective effects against
neuronal cell death in the hippocampus and in the prefrontal
cortex. It can be concluded that chronic stress, due to the
decreased availability of adiponectin receptors, may contribute to
the loss of the favorable effects of adiponectin and, consequently,
may accelerate the progression of AD. Additionally, we could not
demonstrate similar modulating effects of stress in the transgenic
murine model of AD, since the mRNA and protein levels
of adiponectin receptors were not reduced. These unexpected
results suggest that the availability of adiponectin receptors can
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FIGURE 6 | Effects of restraint stress on the expression of AdipoR2 protein in the hippocampus (A) and prefrontal cortex (B) of the wild type and APP/PS1
transgenic mice. Stress-exposed groups were compared to their respective controls (per protein, per brain area, and per mouse strain) by one-way analysis of
variance (ANOVA) followed by Bonferroni and Tukey post hoc tests. Data are expressed as means + SEM (n = 3), *p < 0.05; **p < 0.01.
be stabilized even in cases where genetic and environmental risk
factors for AD co-occur. Recently, Han et al. (2016) demonstrated
that insulin receptor levels are decreased in the hippocampus
of AD mice and can further decline after stress exposure,
concluding that people with harmful genetic mutations are more
likely to be vulnerable to stress. Further investigation is necessary
to explore the mechanism to explain the difference between the
stress-induced changes of adiponectin and insulin receptors.
RS affected adiponectin receptor protein levels less remarkably
than their mRNA, which is not an unexpected finding since
the proteome is much more stable than the mRNA levels.
It is well known, that expression of a given mRNA and
protein do not always match completely, mainly due to post-
transciptional and post-translational control mechanisms. As
post-transcriptional regulators of gene expression, microRNAs
may be partly responsible for the disparate expression of
adiponectin receptors at the protein and RNA levels. A recent
bioinformatics analysis showed that adiponectin signaling is
regulated by microRNAs: miR-221 inhibits AdipoR1 expression,
which suggests that miR-221 regulates AdipoR1 signaling in
different pathological processes (Chen et al., 2015). On the other
hand, AdipoR2 has been identified as a direct target of miR-218
(Du et al., 2015). In our experiments, the expression of AdipoR2
in the prefrontal cortex of AD mice increased significantly at
all time-points of RS, however these changes could not be
measured at the protein level. One potential explanation of our
observations may be the role of miR-218 in this signaling process,
which nevertheless needs further clarification.
The most well characterized adipokine for its role in AD is
leptin (Folch et al., 2012). Population-based studies indicate that
decreased leptin levels are associated with cognitive impairment
(Perez-Gonzalez et al., 2011; Furiya et al., 2013), while higher
leptin levels were associated with a lower risk of dementia (Lieb
et al., 2009; Warren et al., 2012). However, leptin is also involved
in the stress response and stress-related disorders, including
depression and anxiety (Haleem, 2014). Both acute and chronic
stress modify the circulating levels of leptin depending on the
duration of the stress and the stress type itself (Haleem, 2014).
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FIGURE 7 | Effects of restraint stress on the expression of LepR mRNA in the hippocampus (A) and prefrontal cortex (B) of the wild type and APP/PS1
transgenic mice. Stress-exposed groups were compared to their respective controls (per protein, per brain area, and per mouse strain) by one-way analysis of
variance (ANOVA) followed by Bonferroni and Tukey post hoc tests. Data are expressed as means + SEM. (n = 6), *p < 0.05. The gray lines represent linearized
trends of change in the two strains.
Investigation of the effect of RS on LepR’s mRNA expression in
both WT and AD mice showed that LepR is less sensitive to
RS than the adiponectin receptors, since only long-term, chronic
RS decreased the transcription of LepR in the hippocampus of
transgenic mice. This is consistent with previous data obtained
from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
cohort study, which showed decreased LepR immunoreactivity
in brains from individuals suffering severe AD, and similarly the
LepRmRNAwas also reduced only in the old AD transgenic mice
(Maioli et al., 2015). Thus, we propose that APP/PS1 transgenes
and RS do not affect LepR’s transcription as much as they
affect the adiponectin receptors’ transcription. The mechanism
of leptin resistance also seems to be independent from LepR
regulation, which also coincides with our results (Balland and
Cowley, 2015).
Our experiment had several limitations which must be
considered during the evaluation of results. ELISA assays were
performed only for AdipoR1 and AdipoR2 and we only used
three randomly selected protein samples from the six available
for each group to represent one group from the viewpoint of
stress exposure. Thus, a major limitation in the interpretation
of our results is the low number of samples. A study with a
higher sample size may strengthen some of the observations
made in this paper. Furthermore, we did not measure changes
in serum cortisol throughout the experiment, which is one of
the best indicators of psychological stress. The reason behind
this decision was twofold; on the one hand, the stress paradigm
we used is well-documented in the scientific literature to trigger
molecular stress responses in murine models, including the
increase in corticosterone and adrenocorticotropic hormone
secretion (Buynitsky and Mostofsky, 2009). On the other hand,
we wanted to monitor the effect of stress less invasively with
weight measurements to avoid potential alterations in the
resulting data due to the stress of blood sampling.
Frontiers in Neuroscience | www.frontiersin.org 11 April 2017 | Volume 11 | Article 199
Várhelyi et al. Adiponectin Receptors in Alzheimer’s Disease
CONCLUSION
In summary, we were the first to quantitatively investigate
adiponectin receptors concentrations in AD-associated areas
of the brain, namely the hippocampus and the prefrontal
cortex. Based on our results, the expression of adiponectin
receptors AdipoR1 and AdipoR2 are affected by genes APP and
PS1 in a region-specific manner in the brain. These receptor
molecules of adipokine frequently associated with AD are also
influenced by chronic stress in a possibly neurodegeneration-
promoting manner in the hippocampus and prefrontal cortex of
C57BL/6J WT mice. We also demonstrated that in a model of
fully developed AD, an APP(swe)/PSEN(e9d)1 transgene mouse
strain, these receptors respond less plastically or not at all to
the same chronic stress treatment. Furthermore, based on our
observations, LepR plays an essential role only in the late phases
of AD. These results also imply that variation in LepR expression
is not an element of leptin resistance mechanisms.
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